Eric Wehrenberg-Klee
- Oncology top 5%
- Immunology top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Pulmonary and Respiratory Medicine
- Molecular Biology
- Co-authors
- Umar MahmoodBenjamin M. LarimerGenevieve M. BolandTaylor KalomerisAnila MehtaFrank DuboisKeith T. FlahertySuvranu Ganguli
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (11 papers)Cancer Immunotherapy and Biomarkers (11 papers)Immunotherapy and Immune Responses (8 papers)
- Cited by
- OncologyImmunologyHepatology
- Partner nations
- United StatesChinaSwitzerland
In The Last Decade
Eric Wehrenberg-Klee
44 papers receiving 872 citations
Peers
Comparison fields: 5 of 72
- Oncology 477
- Immunology 312
- Radiology, Nuclear Medicine and Imaging 245
- Pulmonary and Respiratory Medicine 176
- Molecular Biology 140
Countries citing papers authored by Eric Wehrenberg-Klee
This map shows the geographic impact of Eric Wehrenberg-Klee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Wehrenberg-Klee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Wehrenberg-Klee more than expected).
Fields of papers citing papers by Eric Wehrenberg-Klee
This network shows the impact of papers produced by Eric Wehrenberg-Klee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Wehrenberg-Klee. The network helps show where Eric Wehrenberg-Klee may publish in the future.
Co-authorship network of co-authors of Eric Wehrenberg-Klee
This figure shows the co-authorship network connecting the top 25 collaborators of Eric Wehrenberg-Klee. A scholar is included among the top collaborators of Eric Wehrenberg-Klee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Wehrenberg-Klee. Eric Wehrenberg-Klee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 10 | |
| 8 | 1 | |
| 9 | 8 | |
| 10 | 20 | |
| 11 | 16 | |
| 12 | 93 | |
| 13 | 17 | |
| 14 | 48 | |
| 15 | 240 | |
| 16 | 2 | |
| 17 | 100 | |
| 18 | 7 | |
| 19 | 19 | |
| 20 | 39 |
About Eric Wehrenberg-Klee
Eric Wehrenberg-Klee is a scholar working on Hepatology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 45 papers that have together received 875 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Immunotherapy and Immune Responses (8 papers). The work is most often cited by research in Oncology (477 citations), Immunology (312 citations) and Hepatology (104 citations). Eric Wehrenberg-Klee has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Umar Mahmood, Benjamin M. Larimer, Genevieve M. Boland, Taylor Kalomeris, Anila Mehta, Frank Dubois, Keith T. Flaherty, Suvranu Ganguli, S. William Stavropoulos and Emily Bloch. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.